Position in TCRT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,889
+$22 QoQ
Shares Held
836
+28.0% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 29 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TCRT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. TCRT ranks #457 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in TCRT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,889 | 836 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,867 | 653 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,319 | 1,647 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $4,058 | 1,684 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $8,719 | 1,798 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,317 | 897 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,996 | 1,046 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $4,304 | 1,337 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $10,456 | 14,940 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $30,941 | 17,095 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $17,132 | 244,755 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $42,570 | 327,468 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $309,693 | 607,246 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $418,002 | 663,501 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $922,889 | 1,419,833 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,283,137 | 746,011 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,087,526 | 877,041 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $625,652 | 962,544 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $980,225 | 899,291 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,720,658 | 945,419 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,762,325 | 1,046,336 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $3,327,119 | 924,200 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,139,687 | 1,245,908 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,232,883 | 886,065 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,030,444 | 923,916 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||